查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545523

全球數位 PCR 市場

Digital PCRs
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球數位 PCR 市場預計將達到 3.712 億美元

預計 2023 年全球數位 PCR 市場規模為 2.172 億美元，預計到 2030 年將達到 3.712 億美元，2023 年至 2030 年複合年成長率為 8.0%。基礎研究應用是本報告分析的細分市場之一，預計複合年成長率為 8.0%，到分析期結束時將達到 1.507 億美元。分析期間，臨床診斷應用領域的複合年成長率預計為8.5%。

美國市場預估為5,980萬美元，中國預期複合年成長率為7.3%

預計 2023 年美國數位 PCR 市場規模將達到 5,980 萬美元。中國作為全球第二大經濟體，預計2030年市場規模將達5,670萬美元，2023-2030年分析期間複合年成長率為7.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 7.3% 和 6.5%。在歐洲，德國的複合年成長率預計約為 6.4%。

全球數位PCR市場趨勢及促進因素總結

什麼是數位 PCR？

數位 PCR (dPCR) 是一種高度準確且靈敏的分子技術，用於定量和擴增 DNA 或 RNA。此方法將樣品分成許多單獨的反應。 PCR 擴增後，對每個分區進行分析以確定目標序列是否存在，從而比傳統 PCR 方法進行更準確的定量。數位 PCR 提供絕對定量，無需參考標準或內部對照，顯著提高檢測低豐度標靶、評估基因表現量和分析遺傳變異的置信度。這項技術在臨床診斷、個人化醫療和環境生物學中特別有價值，因為準確的測量非常重要。

科技進步如何提升數位 PCR 的能力？

數位 PCR 的最新技術進步包括流體動態、微流體和軟體分析的改進，提高了這些系統的準確性、易用性和吞吐量。液滴數位 PCR (ddPCR) 和基於晶片的 dPCR 等創新徹底改變了該領域，透過增加分析的分區數量提供更高的靈敏度和準確性。這些進步使研究人員能夠以前所未有的精確度檢測罕見的 DNA 目標，例如血液樣本中低濃度的腫瘤 DNA。此外，自動化和即時資料分析軟體的整合減少了人為錯誤的可能性並簡化了工作流程，使數位 PCR 成為高通量環境中常規使用的強大工具。

數位 PCR 技術正在推動哪些應用？

數位 PCR 在基礎研究以外的各種應用中變得越來越重要。在臨床診斷中，它用於早期檢測癌症突變和感染疾病、監測微小殘留疾病並追蹤治療效果，這可以直接影響患者的治療計劃和結果。在環境監測領域，dPCR 可以檢測土壤和水樣本中的低水平病原體和基因改造作物。此外，在快速發展的液態切片領域，dPCR 可以透過檢測和量化循環腫瘤 DNA 來幫助非侵入性癌症診斷，為早期診斷、預後預測和疾病監測提供強大的工具。每個應用都受益於 dPCR 的高靈敏度和精確度，推動其融入這些重要的研究和應用領域。

什麼將推動數位PCR市場的成長？

數位 PCR 市場的成長受到多種因素的推動，包括對需要強大定量技術的精確分子診斷和個人化醫療的需求不斷成長。遺傳疾病和癌症盛行率的上升，加上液態切片的認知和臨床應用的不斷提高，將進一步推動對數位 PCR 技術的需求。提高 dPCR 裝置效率並降低成本的技術創新也有助於市場擴張。此外，dPCR在食品安全、環境監測、農業生物學等領域的應用範圍不斷擴大，凸顯了其多功能性和有效性，吸引了各領域的投資。這些因素，加上數位 PCR 系統的不斷改進和對精確診斷的日益重視，確保了 dPCR 市場的持續擴大，反映了分子生物學和臨床診斷的未來重要性。

受訪企業範例（共46家）

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP11555

Global Digital PCRs Market to Reach US$371.2 Million by 2030

The global market for Digital PCRs estimated at US$217.2 Million in the year 2023, is expected to reach US$371.2 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$59.8 Million While China is Forecast to Grow at 7.3% CAGR

The Digital PCRs market in the U.S. is estimated at US$59.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

Select Competitors (Total 46 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Digital PCRs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Propels Adoption of Digital PCRs
    • Increasing Use of Digital PCR in Cancer Diagnostics Expands Market Opportunities
    • Expanding Applications of Digital PCR in Infectious Disease Testing Sets the Stage for Market Growth
    • Rising Adoption of Digital PCRs in Liquid Biopsy Technologies Drives Market Expansion
    • Increasing Use of Digital PCRs in Agricultural Biotechnology Bodes Well for Market Growth
    • Growing Focus on Non-Invasive Prenatal Testing (NIPT) Spurs Adoption of Digital PCRs
    • Growing Use of Digital PCR in Environmental Testing Expands Addressable Market
    • Expansion of Digital PCR in Food Safety Testing Generates Market Opportunities
    • Rising Prevalence of Genetic Disorders Sets the Stage for Growth in Digital PCR Market
    • Development of Portable Digital PCR Devices Bodes Well for Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Digital PCRs Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION